1Orrego H,Blendis L M,Crossley I R,et al.Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat[J].Gastroenterology,1981,80(3):546-556.
2Albrecht T,Blomley M J,Cosgrove D O,et al.Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent[J].Lancet,1999,353(9164):1579-1583.
3Lim A K,Taylor-Robinson S D,Patel N,et al.Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C[J].Gut,2005,54(1):128-133.
4Hirota M,Kaneko T,Sugimoto H,et al.Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis[J].Liver Int,2005,25(2):337-342.
6Blomley M J,Lim A K,Harvey C J,et al.Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease:a cross sectional study[J].Gut,2003,52(8):1188-1193.
7Kaneko T,Teshigawara O,Sugimoto H,et al.Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver[J].Liver Int,2005,25(2):288-293.
8Forsberg F,Goldberg B B,Liu J B,et al.Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma[J].Radiology,1999,210(1):125-132.
9Blomley M J,Albrecht T,Cosgrove D O,et al.Stimulated acoustic emission to patients with and without liver disease[J].Ultrasound Med Biol,1999,25(9):1341-1352.
2[1]Gaiani S,Gramantieri L,Venturoli N,et al.What is the criterion of differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy[J].J Hepatol,1997,27(6):979-985.
3[2]Khan KN,Yamasaki M,Yamasaki K,et al.Proposed abdominal sonographic staging to predict severity of liver diseases:analysis with peritoneoscopy and histology[J].Dig Dis Sci,2000,45(3):554-564.
4[3]Zoli M,Magalotti D,Bianchi G,et al.Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis[J].J Hepatol,1995,23(2):129-134.
5[4]Albrecht T,Blomley MJ,Cosgrove DO,et al.Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent[J].Lancet,1999,353(9164):1579-1583.
6[5]Sanford NL,Walsh P,Matis C,et al.Is ultrasonography useful in the assessment of diffuse parenchymal liver disease[J]? Gastroenterology,1985,89(1):186-191.
7[6]Vilgrain V.Ultrasound of diffuse liver disease and portal hypertension[J].Eur Radiol,2001,11(9):1563-1577.
8[8]Numata K,Tanaka K,Kiba T,et al.Contrast-enhanced,wide-band harmonic gray scale imaging of hepatocellular carcinoma:correlation with helical computed tomographic findings[J].J Ultrasound Med,2001,20(2):89-98.
10[10]Gaiani S,Serra C,Piscaglia F,et al.Effect of Levovist on splanchnic hemodynamics in cirrhotic patients[J].Ultrasound Med Biol,2003,29(5):643-648.